vimarsana.com
Home
Live Updates
Screening uptake of colonoscopy versus fecal immunochemical
Screening uptake of colonoscopy versus fecal immunochemical
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
In a randomized trial Natalia González-López and co-workers investigate whether fecal immunochemical testing improves screening uptake in first degree relatives of patients with non-syndromic colorectal cancer.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Canary Islands ,
Spain General ,
Spain ,
Valencia ,
Carabobo ,
Venezuela ,
Madrid ,
Poland ,
Paris ,
France General ,
France ,
Netherlands ,
Spanish ,
Dutch ,
Polish ,
Salud Carlos ,
Gastroenterologiay Hepatologia ,
Elsevier ,
World Health Organization ,
Fujifilm ,
Colonoscopy Screening Program ,
Scientific Committee ,
Creative Commons Attribution License ,
Supporting Information ,
Instituto De Salud Carlos ,
Spanish Government ,
World Health ,
Clinical Research Ethics Committee ,
Hospital Universitario De Canarias ,
Basque Country ,
Consolidated Standards ,
Reporting Trials ,
Redcap Electronic Data Capture ,
Polish Colonoscopy Screening Program ,
Colonoscopy ,
Colorectal Cancer ,
Adenomas ,
Cancer Risk Factors ,
Regression Analysis ,
Cancer Detection And Diagnosis ,
Cancer Screening ,
Invasive Tumors ,